TrialDiabetes/metabolism research and reviews2020

The effects of canagliflozin compared to sitagliptin on cardiorespiratory fitness in type 2 diabetes mellitus and heart failure with reduced ejection fraction: The CANA-HF study.

Salvatore Carbone et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.